FABP1 and fatty liver disease: We also explored whether the observed protection against hepatic steatosis in the LFABPliv-/- mice might also be influenced by compensatory responses in the intestine to the liver-specific ablation of LFABP, since LFABP is still expressed in the proximal small intestine where intestinal lipid processing primarily occurs.